Swedish Orphan Biovitrum AB (publ) (SOBI) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Swedish Orphan Biovitrum AB (publ) (SOBI) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.13 Billion ≈ $121.18 Million USD) by net assets (Skr40.38 Billion ≈ $4.35 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SOBI market cap overview for the company's overall valuation and market capitalisation.

Swedish Orphan Biovitrum AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Swedish Orphan Biovitrum AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Swedish Orphan Biovitrum AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Swedish Orphan Biovitrum AB (publ) ranked by their cash flow conversion efficiency. Explore Swedish Orphan Biovitrum AB (publ) cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Medpace Holdings Inc NASDAQ:MEDP	0.373x
Toast Inc NYSE:TOST	0.070x
News Corporation AU:NWSLV	0.055x
Banco Santander Chile NYSE:BSAC	-0.042x
Cholamandalam Investment and Finance Company Limited NSE:CHOLAFIN	-1.249x
Ast Spacemobile Inc NASDAQ:ASTS	-0.040x
WESCO International Inc NYSE:WCC	0.010x
Beiersdorf Aktiengesellschaft F:BEIA	0.019x

Annual Cash Flow Conversion Efficiency for Swedish Orphan Biovitrum AB (publ) (2002–2025)

The table below shows the annual cash flow conversion efficiency of Swedish Orphan Biovitrum AB (publ) from 2002 to 2025. View Swedish Orphan Biovitrum AB (publ) share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr37.72 Billion ≈ $4.06 Billion	Skr8.56 Billion ≈ $921.62 Million	0.227x	+23.82%
2024-12-31	Skr40.30 Billion ≈ $4.34 Billion	Skr7.39 Billion ≈ $795.07 Million	0.183x	+38.91%
2023-12-31	Skr33.87 Billion ≈ $3.64 Billion	Skr4.47 Billion ≈ $481.04 Million	0.132x	-24.95%
2022-12-31	Skr26.52 Billion ≈ $2.85 Billion	Skr4.67 Billion ≈ $502.03 Million	0.176x	-25.40%
2021-12-31	Skr23.20 Billion ≈ $2.50 Billion	Skr5.47 Billion ≈ $588.66 Million	0.236x	-8.64%
2020-12-31	Skr20.21 Billion ≈ $2.17 Billion	Skr5.21 Billion ≈ $561.11 Million	0.258x	+20.22%
2019-12-31	Skr16.93 Billion ≈ $1.82 Billion	Skr3.63 Billion ≈ $391.08 Million	0.215x	-7.17%
2018-12-31	Skr9.04 Billion ≈ $972.86 Million	Skr2.09 Billion ≈ $224.95 Million	0.231x	+16.23%
2017-12-31	Skr6.70 Billion ≈ $721.08 Million	Skr1.33 Billion ≈ $143.45 Million	0.199x	+210.66%
2016-12-31	Skr5.35 Billion ≈ $576.21 Million	Skr342.86 Million ≈ $36.90 Million	0.064x	-40.80%
2015-12-31	Skr4.69 Billion ≈ $504.65 Million	Skr507.20 Million ≈ $54.58 Million	0.108x	+109.27%
2014-12-31	Skr4.52 Billion ≈ $486.73 Million	Skr233.77 Million ≈ $25.16 Million	0.052x	+32.97%
2013-12-31	Skr4.77 Billion ≈ $513.25 Million	Skr185.39 Million ≈ $19.95 Million	0.039x	-53.62%
2012-12-31	Skr4.84 Billion ≈ $520.65 Million	Skr405.47 Million ≈ $43.64 Million	0.084x	+304.14%
2011-12-31	Skr4.96 Billion ≈ $534.14 Million	Skr102.93 Million ≈ $11.08 Million	0.021x	+141.86%
2010-12-31	Skr4.34 Billion ≈ $467.31 Million	Skr-215.10 Million ≈ $-23.15 Million	-0.050x	-213.80%
2009-12-31	Skr1.35 Billion ≈ $145.58 Million	Skr58.88 Million ≈ $6.34 Million	0.044x	+111.04%
2008-12-31	Skr1.28 Billion ≈ $138.28 Million	Skr-506.49 Million ≈ $-54.51 Million	-0.394x	-2156.87%
2007-12-31	Skr1.45 Billion ≈ $156.34 Million	Skr-25.37 Million ≈ $-2.73 Million	-0.017x	+72.56%
2006-12-31	Skr1.38 Billion ≈ $148.70 Million	Skr-87.96 Million ≈ $-9.47 Million	-0.064x	-66.41%
2005-12-31	Skr1.71 Billion ≈ $183.77 Million	Skr-65.32 Million ≈ $-7.03 Million	-0.038x	+62.02%
2004-12-31	Skr2.08 Billion ≈ $223.37 Million	Skr-209.03 Million ≈ $-22.50 Million	-0.101x	-127.94%
2003-12-31	Skr2.10 Billion ≈ $225.57 Million	Skr755.60 Million ≈ $81.31 Million	0.360x	+6368.45%
2002-12-31	Skr1.73 Billion ≈ $185.73 Million	Skr9.62 Million ≈ $1.04 Million	0.006x	--

About Swedish Orphan Biovitrum AB (publ)

ST:SOBI Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$16.36 Billion

Skr152.03 Billion SEK

Market Cap Rank

#1528 Global

#22 in Sweden

Share Price

Skr439.60

Change (1 day)

-1.92%

52-Week Range

Skr272.60 - Skr480.00

All Time High

Skr480.00